Medicus Pharma Ltd. Common Stock (MDCXW)
R&D Expense Growth
118.87%
Fiscal year · Period ending:
MDCXW R&D Expense Growth
Latest reported118.87%period ending
Latest reported118.87%period ending
MDCXW FY R&D Growth (YoY) (0.00% → 118.87%)
Latest values, visible window
High-resolution chart · PNG
MDCXW r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 118.8748% | |
| 1,722.4106% | |
| -70.0522% | |
| -45.3781% | |
| 0% |